tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MGNX Stock Latest News

MacroGenics price target lowered to $2 from $4 at H.C. Wainwright
The FlyMacroGenics price target lowered to $2 from $4 at H.C. Wainwright
4d ago
MGNX
MacroGenics: Hold Rating Amidst Development Halts and Financial Challenges
PremiumRatings
MacroGenics: Hold Rating Amidst Development Halts and Financial Challenges
4d ago
MGNX
MacroGenics Inc’s 2024 Earnings Call Highlights
PremiumCompany Announcements
MacroGenics Inc’s 2024 Earnings Call Highlights
8d ago
MGNX
MacroGenics Hold Rating: Uncertainty in Pipeline and Fair Valuation Amidst Anticipated 2025 Updates
PremiumRatings
MacroGenics Hold Rating: Uncertainty in Pipeline and Fair Valuation Amidst Anticipated 2025 Updates
8d ago
MGNX
MacroGenics Reports 2024 Financial Results and Progress
PremiumCompany Announcements
MacroGenics Reports 2024 Financial Results and Progress
8d ago
MGNX
MacroGenics Inc (MGNX) Q4 Earnings Cheat Sheet
PremiumPre-EarningsMacroGenics Inc (MGNX) Q4 Earnings Cheat Sheet
27d ago
MGNX
MacroGenics Extends CEO’s Separation Agreement
Premium
Company Announcements
MacroGenics Extends CEO’s Separation Agreement
1M ago
8K
MGNX
MacroGenics Announces Leadership Transition in Financial Roles
Premium
Company Announcements
MacroGenics Announces Leadership Transition in Financial Roles
4M ago
8K
MGNX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
EBS
ACAD
MacroGenics downgraded to Market Perform from Outperform at JMP Securities
PremiumThe Fly
MacroGenics downgraded to Market Perform from Outperform at JMP Securities
5M ago
MGNX
MacroGenics Margenza rights sale a positive, says Leerink
PremiumThe Fly
MacroGenics Margenza rights sale a positive, says Leerink
5M ago
MGNX
MacroGenics Inc. Reports Strong Revenue Growth
PremiumCompany Announcements
MacroGenics Inc. Reports Strong Revenue Growth
5M ago
MGNX
MacroGenics reports Q3 EPS 90c, consensus 21c
PremiumThe FlyMacroGenics reports Q3 EPS 90c, consensus 21c
5M ago
MGNX
Is MGNX a Buy, Before Earnings?
Premium
Pre-Earnings
Is MGNX a Buy, Before Earnings?
5M ago
MGNX
MacroGenics Announces CEO Transition Amidst Strong Growth
Premium
Company Announcements
MacroGenics Announces CEO Transition Amidst Strong Growth
5M ago
8K
MGNX
MacroGenics announces CEO Koenig to step down
PremiumThe Fly
MacroGenics announces CEO Koenig to step down
5M ago
MGNX
MacroGenics in $40M deal with TerSera Therapeutics for sale of Margenza
PremiumThe Fly
MacroGenics in $40M deal with TerSera Therapeutics for sale of Margenza
5M ago
MGNX
MacroGenics announces updated efficacy, safety data from TAMARACK Phase 2 study
PremiumThe Fly
MacroGenics announces updated efficacy, safety data from TAMARACK Phase 2 study
7M ago
MGNX
MacroGenics price target lowered to $14 from $16 at Citi
PremiumThe Fly
MacroGenics price target lowered to $14 from $16 at Citi
8M ago
MGNX
MacroGenics management to meet virtually with B. Riley
PremiumThe FlyMacroGenics management to meet virtually with B. Riley
8M ago
MGNX
MacroGenics management to meet virtually with B. Riley
Premium
The Fly
MacroGenics management to meet virtually with B. Riley
8M ago
MGNX
MacroGenics management to meet virtually with B. Riley
Premium
The Fly
MacroGenics management to meet virtually with B. Riley
8M ago
MGNX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >